Active substances
Dexamethasone + Neomycin
- SFDA 1
- US FDA 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| NEODEX 0.1 E-E DROP | 1,5 mg,mg | Ear/eye drops, solution · Auricular use | 1 Dropper Container | SAR 11.30 | NCE · Prescription | Amman Pharmaceutical Industries (API) | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NEODECADRON | EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML | solution/drops · ophthalmic | MERCK | Discontinued | 2 Jul 1969 |
| NEODECADRON | EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM | ointment · ophthalmic | MERCK | Discontinued | 15 Sep 1969 |
| NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE | EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML | solution/drops · ophthalmic | ALCON PHARMS LTD | Discontinued | 21 Jul 1986 |
| NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE | EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML | solution/drops · ophthalmic | BAUSCH AND LOMB | Discontinued | 30 Oct 1995 |
| NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE | EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML | solution/drops · ophthalmic | PHARMAFAIR | Discontinued |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.